12:00 AM
 | 
Jan 14, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Afirma Gene Expression Classifier regulatory update

The National Comprehensive Cancer Network (NCCN) updated its clinical practice guidelines in oncology for thyroid cancer to recommend that physicians should consider using molecular testing in lieu of diagnostic surgery when a thyroid nodule fine needle...

Read the full 157 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >